Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Apply
AVB-101
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step